Work

The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells

Year: 2006

Type: article

Source: Investigational New Drugs

DOI: 10.1007/s10637-006-9018-3

Authors: Tracy A. Brooks, Kieran L. O’Loughlin, Hans Minderman, Brian N. Bundy, Laurie A. Ford, Michael R. Vredenburg, Ralph J. Bernacki, Waldemar Priebe, Maria R. Baer

Institutions: Roswell Park Comprehensive Cancer Center, University of Arizona, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: Drug Development and Cancer Treatments, DEVELOPMENT OF NEW SEMISYNTHETIC TAXANES, Broad Spectrum MDR Modulation in AML, G8108348530, Roswell Park Cancer Center Support Grant

OpenAlex ID: W2021750163

FWCI: 0.93

Cites: 17

Cited by: 17

Related to: 10